FDA Adverse Event Injury Summary report: N

TRIDENT 10° X3 INSERT 36MM ID

MDR report key: 3163098 · Received June 11, 2013

Report

Report Number
0002249697-2013-01882
Event Type
Injury
Date Received
June 11, 2013
Date of Event
May 14, 2013
Report Date
May 15, 2013
Manufacturer
STRYKER ORTHOPAEDICS-MAHWAH
Product Code
JDI
PMA / PMN Number
K033716
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AN EVALUATION OF THE DEVICE CANNOT BE PERFORMED AS THE DEVICE WAS RETAINED BY THE PATIENT AND WAS NOT RETURNED TO THE MANUFACTURER. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THE EVALUATION SUMMARY WILL BE SUBMITTED IN A SUPPLEMENTAL REPORT. (B)(4): NOT RETURNED TO THE MANUFACTURER.

Additional Manufacturer Narrative · 1

AN EVENT DESCRIPTION CONSISTENT WITH THE HARMS ASSOCIATED WITH (B)(4) WAS REPORTED. THE EVENT NOTED THAT THE LINER WAS REVISED DUE TO "DISCOLORATION." THE EVENT DID NOT ALLEGE ANY FUNCTIONAL DEFICIENCY OR FAILURE OF THE SUBJECT ACETABULAR LINER AT THE TIME OF REVISION. DISCOLORATION IS A KNOWN EFFECT OF USE ATTRIBUTED TO IN-VIVO ABSORPTION OF SYNOVIAL FLUID AND DOES NOT AFFECT THE FUNCTIONALITY OF THE DEVICE. BASED ON THIS INFORMATION, IT IS BELIEVED THE LINER WAS REPLACED AS A PRECAUTIONARY MEASURE WHILE IT WAS EASILY ACCESSIBLE.

Description of Event or Problem · 1

IT WAS REPORTED THAT DR. (B)(6) STATES PATIENT PRESENTED WITH INCREASED PAIN IN JOINT AREA, ELEVATED CHROME AND COBALT SERUM LEVELS, POSITIVE MARS SCAN. DR. (B)(6) DECIDED TO EXHANGE LINER BECAUSE OF DISCOLORATION OF LINER.

Description of Event or Problem · 1

IT WAS REPORTED THAT DR. (B)(6) STATES PATIENT PRESENTED WITH INCREASED PAIN IN JOINT AREA, ELEVATED CHROME AND COBALT SERUM LEVELS, POSITIVE MARS SCAN. DR. (B)(6) DECIDED TO EXCHANGE LINER BECAUSE OF DISCOLORATION OF LINER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
263661 TRIDENT 10° X3 INSERT 36MM ID IMPLANT JDI STRYKER ORTHOPAEDICS-MAHWAH MJD14D

Patients

Seq Age Sex Outcome Treatment
1 57 YR Required Intervention